Literature DB >> 31871223

Community-Based Upper Gastrointestinal Cancer Screening in a Randomized Controlled Trial: Baseline Results in a Non-high-incidence Area.

Hai-Fan Xiao1, Shi-Peng Yan1, Yan-Fang Chen2, Zhaohui Shi1, Yan-Hua Zou1, Song-Lin Zhu1, Ke-Kui Xu1, Ting Song2, Xian-Zhen Liao3.   

Abstract

A cluster-randomized controlled trial (RCT) was conducted to evaluate to the effectiveness of reducing mortality of upper gastrointestinal cancer (UGC) and feasibility of screening through a questionnaire combined with endoscopy in non-high-incidence urban areas in China. The trial design, recruitment performance, and preliminary results from baseline endoscopy are reported. Seventy-five communities in two urban cities with a non-high-incidence of UGC were randomized to a screening endoscopy arm (n = 38) or a control arm (n = 37). In the screening arm, individuals at high risk of UGC underwent endoscopic screening. The primary outcome was the UGC mortality, and secondary outcomes included the UGC detection rate, incidence rate, survival rate, and clinical stage at the time of diagnosis. A total of 10,416 and 9,565 individuals were recruited into the screening and control arms, respectively. The participation rate was 74.3%. In the screening arm, 5,242 individuals (50.3%) were estimated to be high-risk. Among them, 2,388 (45.6%) underwent endoscopic screening. Age and household income were associated with undergoing endoscopy. Three early esophageal cancer (0.13%), one gastric cancer (0.04%), 29 precancerous esophageal lesions (1.21%), and 53 precancerous gastric lesions (2.22%) were detected. Age, sex, a family history of cancer, intake of meat-egg-milk frequently, superficial gastritis, and clinical symptoms of gastric cancer were associated with the presence of precancerous lesions. The detection rate was low using endoscopic screening in non-high-incidence area given the relatively low compliance rate. These findings provide a reference for designing effective community-based UGC screening strategies in non-high-incidence urban areas. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31871223     DOI: 10.1158/1940-6207.CAPR-19-0422

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  2 in total

1.  A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial results.

Authors:  Xiao-Yang Wang; Shu-Zheng Liu; Hui-Fang Xu; Yin Liu; Hong Wang; Rui-Hua Kang; Qiong Chen; Lu-Yao Zhang; Lan-Wei Guo; Li-Yang Zheng; Chun-Ya Liu; Yi-Xian Wang; Yi-Ping Jing; You-Lin Qiao; Bin-Bin Han; Shao-Kai Zhang
Journal:  Ann Transl Med       Date:  2022-09

2.  Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area.

Authors:  Hai-Fan Xiao; Shi-Peng Yan; Ji-Gang Li; Zhao-Hui Shi; Yan-Hua Zou; Ke-Kui Xu; Xian-Zhen Liao
Journal:  Cancer Med       Date:  2020-09-16       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.